Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 859

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 4
Chunk 859
---
4, the Company issued:

    ●
    797,345
    shares of common stock to settle $1.9 million of principal and $0.3 million of interest on a Convertible Note and incurred $0.8 of
    loss on settlement (see Note 5).

    ●
    395,574
    shares of common stock as part of a public offering.

    ●
    29,997
    shares of common stock issued for vesting of restricted stock units.

    ●
    729,246
    shares of common stock issued for the exercise of pre-funded warrants.

    ●
    115,716
    shares of common stock issued for the reverse stock split fractional share round up.

During
the year ended December 31, 2023, the Company issued:

    ●
    297,625
    shares of common stock to settle $1.9 million of principal and $0.3 million of interest on a Convertible Note and incurred $0.5 million
    of loss on settlement.

    ●
    10,650
    shares of common stock issued for vesting of restricted stock units.

October
2024 Equity Financing

In
July 2024, the Company entered into an agreement with A.G.P./Alliance Global Partners (“AGP”), as the exclusive underwriter,
placement agent, or advisor in a public or private offering of up to $10,000,000 of the Company’s securities. Under the agreement,
AGP was paid a $50,000 retainer fee.

On
October 31, 2024, AGP served as lead underwriter along with Boustead as co-underwriter for the Company to consummate a public offering
(the “Public Offering”) of an aggregate of (i) 395,574 shares of common stock (the “Common Stock”) and 2,555,246
pre-funded warrants to purchase up to 2,555,246 shares of common stock (the “Pre-Funded Warrants”), and (ii) 2,950,820 common
stock purchase warrants to purchase up to 2,950,820 shares of common stock (the “Common Warrants”). Each share of common
stock, or a pre-funded warrant in lieu thereof, was sold together with an accompanying warrant to purchase one share of common stock.

The
public offering price for each share of Common Stock and one accompanying Common Warrant was $1.525. The public